151 related articles for article (PubMed ID: 33638929)
21. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.
Kim HS; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Park YN; Han DH; Kim KS; Choi JS; Choi GH; Kim HS
Clin Mol Hepatol; 2020 Jan; 26(1):33-44. PubMed ID: 31243939
[TBL] [Abstract][Full Text] [Related]
22. Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy.
Donadon M; Di Tommaso L; Soldani C; Franceschini B; Terrone A; Mimmo A; Vitali E; Roncalli M; Lania A; Torzilli G
Liver Int; 2018 Feb; 38(2):303-311. PubMed ID: 28727243
[TBL] [Abstract][Full Text] [Related]
23. Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection.
Lin CW; Chen YS; Lin CC; Lee PH; Lo GH; Hsu CC; Hsieh PM; Koh KW; Chou TC; Dai CY; Huang JF; Chuang WL; Chen YL; Yu ML
Clin Transl Gastroenterol; 2018 Jul; 9(6):166. PubMed ID: 29961754
[TBL] [Abstract][Full Text] [Related]
24. Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
Yang Y; Chen Y; Ye F; Cao X; Xin Y; Wang Y; Lei Y; Li X; Feng D; Zhou X; Fan Q
Eur Radiol; 2021 May; 31(5):3053-3064. PubMed ID: 33175203
[TBL] [Abstract][Full Text] [Related]
25. Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model.
Jung KS; Kim JH; Kim SU; Song K; Kim BK; Park JY; Kim DY; Ahn SH; Moon DC; Song IJ; Choi GH; Park YN; Han KH
PLoS One; 2014; 9(6):e99167. PubMed ID: 24910997
[TBL] [Abstract][Full Text] [Related]
26. Serum antibody titers against hepatitis C virus and postoperative intrahepatic recurrence of hepatocellular carcinoma.
Uemura M; Sasaki Y; Yamada T; Gotoh K; Eguchi H; Yano M; Ohigashi H; Ishikawa O; Imaoka S
Ann Surg Oncol; 2014 May; 21(5):1719-25. PubMed ID: 24464342
[TBL] [Abstract][Full Text] [Related]
27. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
28. Elevated pretherapy serum IL17 in primary hepatocellular carcinoma patients correlate to increased risk of early recurrence after curative hepatectomy.
Wu J; Du J; Liu L; Li Q; Rong W; Wang L; Wang Y; Zang M; Wu Z; Zhang Y; Qu C
PLoS One; 2012; 7(12):e50035. PubMed ID: 23227158
[TBL] [Abstract][Full Text] [Related]
29. Nomogram predicting survival of hepatocellular carcinoma with portal vein tumour thrombus after curative resection.
Hu Y; You S; Yang Z; Cheng S
ANZ J Surg; 2019 Jan; 89(1-2):E20-E25. PubMed ID: 30117625
[TBL] [Abstract][Full Text] [Related]
30. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis.
Ko S; Nakajima Y; Kanehiro H; Hisanaga M; Aomatsu Y; Kin T; Yagura K; Ohyama T; Nishio K; Ohashi K; Sho M; Yamada T; Nakano H
Ann Surg; 1996 Nov; 224(5):591-5. PubMed ID: 8916872
[TBL] [Abstract][Full Text] [Related]
31. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
[TBL] [Abstract][Full Text] [Related]
32. A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study.
Zhang XP; Chen ZH; Zhou TF; Li LQ; Chen MS; Wen TF; Shi J; Guo WX; Wu MC; Lau WY; Cheng SQ;
Eur J Surg Oncol; 2019 Sep; 45(9):1644-1651. PubMed ID: 30982657
[TBL] [Abstract][Full Text] [Related]
33. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma.
Sasaki Y; Yamada T; Tanaka H; Ohigashi H; Eguchi H; Yano M; Ishikawa O; Imaoka S
Ann Surg; 2006 Nov; 244(5):771-80. PubMed ID: 17060771
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
Li T; Qin LX; Gong X; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
Cancer; 2013 Jan; 119(1):126-35. PubMed ID: 22736338
[TBL] [Abstract][Full Text] [Related]
35. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of hepatocyte nuclear factors 4α and 1α identified by tissue microarray in resectable hepatocellular carcinoma.
Shim JH; Kang HJ; Han S; Lee YJ; Lee SG; Yu E; Lee HC
J Gastroenterol Hepatol; 2014 Mar; 29(3):524-32. PubMed ID: 23981200
[TBL] [Abstract][Full Text] [Related]
37. The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery.
Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
Dig Surg; 2018; 35(3):243-251. PubMed ID: 28810252
[TBL] [Abstract][Full Text] [Related]
38. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
39. Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.
Young SH; Chau GY; Lee IC; Yeh YC; Chao Y; Huo TI; Su CW; Lin HC; Hou MC; Lee MH; Huang YH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):218-229. PubMed ID: 31104872
[TBL] [Abstract][Full Text] [Related]
40. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]